Mycobacteria Registry Study: Prospective Observational Study in Austria
Ludwig Boltzmann Institute for Lung Health
1,000 participants
Jan 1, 2023
OBSERVATIONAL
Conditions
Summary
The goal of this non-interventional registry study is to systematically collect epidemiological and clinical data throughout the treatment course to learn about effectiveness of treatments. We will document the natural course of therapy without additional interventions. The main question to answer is: What are the risk factors for mortality due to infection with Mycobacteria tuberculosis (TB) or Nontuberculous mycobacteria (NTM) in Austria? Data from participants already receiving treatment as part of their regular medical care for TB or NTM infections will be collected.
Eligibility
Inclusion Criteria3
- patients diagnosed with Mycobacterium tuberculosis or non-tuberculous mycobacteria infection
- individuals aged 18 years or older
- written informed consent
Exclusion Criteria1
- to not comprehend and rightfully judge participation
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06522347